On September 3, 2020 Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for respiratory diseases, cancer, and other indications, reported that members of the management team will participate in the following upcoming investor conferences and will provide a corporate update (Press release, Pieris Pharmaceuticals, SEP 3, 2020, View Source [SID1234564404]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Baird 2020 Virtual Global Healthcare Conference

Wednesday, September 9, 2019 at 11:25AM EDT

H.C. Wainwright 22nd Annual Global Investment Conference

Wednesday, September 16, 2019 at 2:00PM EDT

Additional information regarding these events will be available on the Company’s website at www.pieris.com.

On September 3, 2020 Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for respiratory diseases, cancer, and other indications, reported that members of the management team will participate in the following upcoming investor conferences and will provide a corporate update (Press release, Pieris Pharmaceuticals, SEP 3, 2020, View Source [SID1234564403]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Baird 2020 Virtual Global Healthcare Conference

Wednesday, September 9, 2019 at 11:25AM EDT

H.C. Wainwright 22nd Annual Global Investment Conference

Wednesday, September 16, 2019 at 2:00PM EDT

Additional information regarding these events will be available on the Company’s website at www.pieris.com.

On September 3, 2020 CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, reported that management will participate in three virtual investor conferences including Citi’s 15th Annual BioPharma Conference taking place September 9-10, 2020, the H.C. Wainwright 22nd Annual Global Investment Conference taking place September 14-16, 2020 and the Cantor Global Healthcare Conference taking place September 15-17, 2020 (Press release, CymaBay Therapeutics, SEP 3, 2020, View Source [SID1234564401]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 15th Annual BioPharma Conference
Date: Wednesday, September 9
Time: 1-on-1 meetings only

H.C. Wainwright 22nd Annual Global Healthcare Conference
Date: Monday, September 14
Time: 1:30 pm Eastern Time
Webcast: View Source

Cantor Global Healthcare Conference
Date: Wednesday, September 16
Time: 10:40 am Eastern Time
Webcast: View Source

On September 3, 2020 Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, reported that members of management will participate in fireside chats at the following upcoming virtual investor conferences (Press release, Alector, SEP 3, 2020, View Source [SID1234564400]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 15th Annual BioPharma Virtual Conference, Thursday, September 10, 2020, at 11:40 a.m. ET
Morgan Stanley 18th Annual Global Healthcare Conference, Monday, September 14, 2020, at 12:00 p.m. ET
Live webcasts of each fireside chat will be available on the "Events & Presentations" page within the Investors section of the Alector website at View Source Replays of the webcasts will be available on the Alector website for 30 days following the event.

On September 3, 2020 Rain Therapeutics Inc., a privately-held, clinical stage biotechnology company focused on targeted therapies for patients with cancer, reported that Avanish Vellanki, chairman and chief executive officer of Rain, will present a corporate overview at Citi’s 15th Annual BioPharma Virtual Conference being held September 8-10, 2020 (Press release, Rain Therapeutics, SEP 3, 2020, View Source [SID1234564399]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s Annual BioPharma Conference
Date: Tuesday, September 8
Time: 10:05 a.m. EDT